Elanco is a global, innovation-driven company that develops and markets products to improve animal health and protein production in more than 75 countries. Elanco, a division of Eli Lilly, employs more than 2,500 people worldwide with offices in more than 40 countries. Elanco is committed to protein production, companion animal health and food safety. Elanco products help the food industry produce an abundant supply of safe, nutritious and affordable food. Additionally, they enhance animal health, wellness and the human-pet bond. Elanco Companion Animal Health is leading the way in pet medicine, helping veterinarians help pets live longer, healthier, happier lives. Elanco Food Solutions markets food-safety products and services to the food animal industry. Elanco's global headquarters is in Greenfield, Indiana, USA, and is also the home of the United States business operations.
What Makes Elanco Unique
For more than half a century, Elanco has helped shape the animal health industry around the world. We introduced our first antibiotic for veterinary use only in 1953. Since then, Elanco has brought more than 35 agricultural and animal health products to the global marketplace, including food industry products such as antibacterials, parasiticides, anticoccidials, and productivity enhancers, as well as pet medicines and food safety solutions.
Research & Development
At Elanco, we are committed to developing products that are safe for animals, the environment and the consumer. Our products meet stringent government regulatory and food safety requirements while providing a positive economic return for farm animal production. We have a strong track record of bringing innovation to the global market. Whether for livestock or pets, Elanco is committed to research, development and implementation of products that benefit animals, consumers and the environment. We partner with the most innovative companies worldwide to develop products that increase food production, enhance food safety, and help companion animals live longer, happier, healthier lives.
Elanco Philippines was established in 1964, the new company was responsible for major innovations in the years that followed. As a branch of Lilly’s global animal health division, Elanco marketed and distributed products and services that improve animal health and, with that, the performance of the poultry, beef, pork and dairy-farming sectors in the country.
In recent years Elanco has embarked on a rapid expansion drive, including strategic acquisition. Elanco has acquired Novartis Animal Health in January 2015. A substantial presence in the industry with offering to customers product lines that focus on pleuromutilins, broad spectrum antibiotics, vaccines, fly control/disinfectants and over-the-counter products. Upon the completion of Novartis Animal health acquisition, Elanco will be the second largest animal health company in the world.